Here's what happens during your Glutathione therapy session at InjectCo
(2014) 3:e001075
GLP-1 Drug Market Size, Share, Growth, and Industry Analysis, By Types (Short-acting GLP-1 Drug,Long-acting GLP-1 Drug), By Applications (Obesity,Type 2 Diabetes (T2DM),Cardiovascular and Cerebrovascular Diseases (CVD),Non-alcoholic Steatohepatitis (NASH),Alzheimer's Disease (AD)) , and Regional Insights and Forecast to 2035 Last Updated: 23-March-2026 Base Year: 2025 Historical Data: 2021-2024 Region: Global Report ID: GGI124388 SKU ID: 30248947 Pages: 113 GLP-1 Drug Market Size The Global GLP-1 Drug Market is expanding rapidly, with the market size valued at USD 37.57 billion in 2025 and projected to reach USD 47.6 billion in 2026, further advancing to USD 60.31 billion in 2027 and USD 400.5 billion by 2035, exhibiting a CAGR of 26.7% during the forecast period
If used, creatine is typically reserved for older teens (16+) involved in structured, competitive training, with appropriate adult supervision and a third-party-tested product
The American Medical Association, American Diabetes Association, and other medical organizations recognize obesity as a chronic condition requiring ongoing management, similar to hypertension or diabetes
